Software-As-A-Service Approach to eCTD SubmissionThe chosen solution implemented by Boehringer Ingelheim—eCTDXPress—is ISI’s Web-based solution for creating eCTDs, managing eCTD lifecycles, and reviewing eCTD submissions. read more ...
|
Sample Success Stories of Pharmaceutical companies using AnnoDoc
|
Florida Power ProjectISI's Compose helps Florida Power to become the first plant to publish an electronic FSAR read more ...
|
Chase Manhattan ProjectISI’s Compose is proving to offer huge advantages to a Chase Manhattan, financial services company. read more ...
|
ISI partners with Yamanouchi Co., Ltd., to complete The First eCTD of an NCEYamanouchi approached Image Solutions, Inc. with a business challenge: electronic compilation of the first fully valid, Step 4 compliant, eCTD of an New Chemical Entity (NCE) to the European Authorities. read more ...
|
ISI Aids Foreign Bank in InvestigationForeign Bank in New York City Turns to Image Solutions, Inc.'s DocComposer™ for Hi-Speed PDF Conversion and Full Text Searchability. read more ...
|
First Electronic NDA for Maryland-Based Pharmaceutical CompanyImage Solutions, Inc. assists Maryland-based pharmaceutical company with their first electronic NDA. read more ...
|
Procter & Gamble ProjectImage Solutions, Inc.'s collaboration with Procter & Gamble on a large volume submission read more ...
|
Organon Submission ProjectWorking with Organon, ISI was able to QA and process multiple files within a condensed time frame read more ...
|
Novartis-Exelon ProjectNovartis' Exelon submission leads to FDA standardization of electronic submissions read more ...
|
Regulatory and Safety Paper Documents into Documentum™By using CRFScan and ISIFile, Image Solutions aided a top 10 pharmaceutical company with a large scale scanning project read more ...
|
Pfizer's CRF ProjectISI proves capable of managing very large service projects read more ...
|
Using Roche's Existing CRF Data for Zenepax eCRF SubmissionIntegration of ISI software and services with an existing system prove successful read more ...
|